Clinical trial
Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly…
NCT00003909 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003909 |
|---|---|
| Title | Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma |
| Official title | A Phase I Study of Motexafin Gadolinium (Xcytrin, NSC 695238) and Involved Field Radiation Therapy for Intrinsic Pontine Glioma of Childhood |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Untreated Childhood Brain Stem Glioma |
| Intervention type | Drug, Other, Radiation |
| Interventions | motexafin gadolinium, radiation therapy, pharmacological study |
| Enrollment | 24 |
| Start date | Aug 1, 1999 |
| Primary completion | Mar 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: